Legionella feeleii-associated pneumonia in humans. 1986

W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson

Legionella feeleii has been implicated by serologic studies as the causative agent in an outbreak of Pontiac fever and has been recovered from an institutional water source. Pneumonia caused by this agent has not been described previously. The authors have isolated L. feeleii from two immunosuppressed patients with community-acquired pneumonia and from an institutional water source. One patient survived after treatment with erythromycin. The other patient was leukopenic and died of pneumonia. Isolates exhibited typical cultural and biochemical features of L. feeleii and reacted with L. feeleii serogroup 1 antiserum. L. feeleii serogroup 1 is now known to cause not only Pontiac fever but also pneumonia in humans.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007875 Legionella Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
D007877 Legionnaires' Disease An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion. Legionella pneumophila Infections,Infections, Legionella pneumophila,Legionnaire Disease,Pontiac Fever,Disease, Legionnaire,Disease, Legionnaires',Fever, Pontiac,Infection, Legionella pneumophila,Legionella pneumophila Infection,Legionnaire's Disease,Legionnaires Disease
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias

Related Publications

W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
August 1987, Southern medical journal,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
May 1997, The Journal of infection,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
July 1995, The New Zealand medical journal,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
July 1985, Journal of clinical microbiology,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
January 2021, Frontiers in microbiology,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
January 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
January 2011, Emerging infectious diseases,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
August 2009, Transplant infectious disease : an official journal of the Transplantation Society,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
February 2019, Medical microbiology and immunology,
W A Palutke, and L R Crane, and B B Wentworth, and J G Geiger, and L Cardozo, and A Singhakowinta, and J Bartley, and B E Robinson
October 1994, Microbiology (Reading, England),
Copied contents to your clipboard!